Mary Fisher

Insider Reports History

Entity
Individual
Location
C/O Acorda Therapeutics, Inc., 15 Skyline Drive, Hawthorne, NY
Signature
/s/ Gerald T. Proehl, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Mary Fisher:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Sientra, Inc. Director Common Stock 19.6K $13.9K $0.71 Jun 15, 2023 Direct
Dermata Therapeutics, Inc. Director Common Stock 197K Jan 21, 2025 Direct
Dermata Therapeutics, Inc. Director Warrant (Right to Buy) 197K Jan 21, 2025 Direct
Dermata Therapeutics, Inc. Director Stock Option (Right to Buy) 5K Jan 13, 2025 Direct

Insider Reports Filed by Mary Fisher

Symbol Company Period Transactions Value $ Form Type Date Filed Role
DRMA Dermata Therapeutics, Inc. Jan 21, 2025 2 $0 4 Jan 23, 2025 Director
DRMA Dermata Therapeutics, Inc. Jan 13, 2025 1 $0 4 Jan 14, 2025 Director
DRMA Dermata Therapeutics, Inc. Jan 4, 2024 1 $0 4 Jan 5, 2024 Director
SIEN Sientra, Inc. Jun 15, 2023 1 $0 4 Jun 20, 2023 Director
DRMA Dermata Therapeutics, Inc. Oct 6, 2022 1 $0 4 Oct 7, 2022 Director
DRMA Dermata Therapeutics, Inc. Jul 7, 2022 1 $0 4 Jul 8, 2022 Director
SIEN Sientra, Inc. Jun 9, 2022 1 $0 4 Jun 13, 2022 Director
DRMA Dermata Therapeutics, Inc. Apr 7, 2022 1 $0 4 Apr 8, 2022 Director
DRMA Dermata Therapeutics, Inc. Jan 3, 2022 1 $0 4 Jan 5, 2022 Director
DRMA Dermata Therapeutics, Inc. Aug 17, 2021 1 $0 4 Aug 17, 2021 Director
DRMA Dermata Therapeutics, Inc. Aug 12, 2021 0 $0 3 Aug 12, 2021 Director
SIEN Sientra, Inc. Jun 10, 2021 1 $0 4 Jun 15, 2021 Director